Ouster (OUST) Misses Q3 EPS by 12c; Offer Guidance
Get Alerts OUST Hot Sheet
Join SI Premium – FREE
Ouster (NASDAQ: OUST) reported Q3 EPS of ($0.20), $0.12 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $59.32 million versus the consensus estimate of $57.34 million.
GUIDANCE:
Ouster sees Q4 2026 revenue of $61-64 million, versus the consensus of $62.03 million.
For earnings history and earnings-related data on Ouster (OUST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Tarsus Pharmaceuticals, Inc. (TARS) Misses Q3 EPS by 1293c
- Spyre Therapeutics, Inc. (SYRE) Misses Q3 EPS by 16c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share